LeMaitre Will Announce Third Quarter 2025 Earnings Results on November 6, 2025
LeMaitre Vascular (NASDAQ:LMAT) will release its third quarter 2025 financial results on Thursday, November 6, 2025 after the market close. A conference call to discuss results, business highlights, and outlook is scheduled the same day at 5:00 PM EST. Investors can register for live dial‑in access and a PIN or listen via a live audio webcast and replay at the company's investor site.
LeMaitre Vascular (NASDAQ:LMAT) pubblicherà i risultati finanziari del terzo trimestre 2025 giovedì 6 novembre 2025 dopo la chiusura del mercato. Una conference call per discutere i risultati, i punti salienti del business e le prospettive è prevista nello stesso giorno alle 17:00 EST. Gli investitori possono registrarsi per l’accesso in diretta con PIN o ascoltare tramite una trasmissione audio in diretta e la riproduzione sul sito degli investitori dell’azienda.
LeMaitre Vascular (NASDAQ:LMAT) divulgará sus resultados financieros del tercer trimestre de 2025 el jueves 6 de noviembre de 2025 después de que cierre el mercado. Una llamada de conferencia para discutir resultados, aspectos destacados del negocio y perspectivas está prevista para ese mismo día a las 5:00 PM EST. Los inversionistas pueden registrarse para acceso de marcación en vivo y un PIN o escuchar mediante una transmisión de audio en vivo y la reproducción en el sitio de inversores de la empresa.
LeMaitre Vascular (NASDAQ:LMAT)은 2025년 제3분기 재무 실적을 2025년 11월 6일 목요일 장 마감 후 발표합니다. 같은 날 오후 5:00 EST에 결과, 사업 하이라이트 및 전망을 논의하는 컨퍼런스 콜이 예정되어 있습니다. 투자자들은 라이브 다이얼 인 접속 및 PIN을 등록하거나 회사의 투자자 사이트에서 라이브 오디오 웹캐스트 및 재생을 들을 수 있습니다.
LeMaitre Vascular (NASDAQ:LMAT) publiera ses résultats financiers du troisième trimestre 2025 le jeudi 6 novembre 2025 après la clôture du marché. Une conférence téléphonique pour discuter des résultats, des points forts de l’activité et des perspectives est prévue le même jour à 17 h EST. Les investisseurs peuvent s’inscrire pour accéder à la ligne en direct avec un code PIN ou écouter via une webdiffusion audio en direct et la rediffusion sur le site des investisseurs de l’entreprise.
LeMaitre Vascular (NASDAQ:LMAT) wird seine Ergebnisse für das dritte Quartal 2025 am Donnerstag, 6. November 2025 nach Börsenschluss veröffentlichen. Ein Conference Call zur Besprechung der Ergebnisse, der Geschäftshöhepunkte und des Ausblicks ist am selben Tag um 17:00 Uhr EST geplant. Investoren können sich für den Live-Dial-in-Zugang und eine PIN registrieren oder über einen Live-Audio-Webcast und die Wiederholung auf der Investorenseite des Unternehmens zuhören.
LeMaitre Vascular (NASDAQ:LMAT) ستعلن عن نتائجها المالية للربع الثالث من عام 2025 في الخميس 6 نوفمبر 2025 بعد إغلاق السوق. من المقرر عقد مكالمة مؤتمر لمناقشة النتائج ونقاط القوة في الأعمال وآفاقها في نفس اليوم في الساعة 5:00 مساءً بتوقيت شرق الولايات المتحدة. يمكن للمستثمرين التسجيل للوصول الهاتفي المباشر باستخدام رمز PIN أو الاستماع عبر بث صوتي حي وإعادة عرضه على موقع المستثمرين بالشركة.
LeMaitre Vascular (NASDAQ:LMAT) 将在 2025 年第三季度 财报于 2025 年 11 月 6 日星期四 收盘后发布。同日将举行一场 美东时间下午 5:00 的电话会议，讨论业绩、业务要点和展望。投资者可以注册以获得现场拨入访问和 PIN，或通过公司投资者网站收听现场音频网络广播及回放。
- None.
- None.
BURLINGTON, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2025 financial results on Thursday, November 6, 2025, after the market close. The company has scheduled a conference call for 5:00 PM EST the same day to discuss the results, business highlights, and company outlook.
Access to the live call is available by registering online here. All registrants will receive dial-in information and a PIN allowing them to access the live call. The audio webcast can also be accessed live or via replay at ir.lemaitre.com.
About LeMaitre
LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.
LeMaitre and the LeMaitre logo are registered trademarks of LeMaitre Vascular, Inc.
Contact: Gregory Manker Director, Business Development & Investor Relations LeMaitre Vascular, Inc. +1 781-362-1260 gmanker@lemaitre.com
FAQ
When will LeMaitre Vascular (LMAT) report Q3 2025 earnings?
What time is the LeMaitre Vascular (LMAT) earnings call on November 6, 2025?
How can investors access the LeMaitre Vascular (LMAT) Q3 2025 call?
Will the LeMaitre Vascular (LMAT) Q3 2025 webcast be available after the call?
What will LeMaitre Vascular (LMAT) cover on the November 6, 2025 call?
Where can I register for LeMaitre Vascular (LMAT) Q3 2025 earnings call access?
